Fecal inulin content will be measured using short acid hydrolysis and high-performance liquid chromatography
| Group | Value | 95% CI |
|---|---|---|
| Healthy Volunteers | 45.2 | 34.6 – 58.6 |
Last reviewed · How we verify
Healthy Volunteer Short Chain Fatty Acid Study
NA trial testing Inulin in Healthy in 29 participants. Terminated before completion.
| Lead sponsor | Indiana University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 29 |
| Start date | 1 August 2021 |
| Primary completion | 31 July 2023 |
| Estimated completion | 31 July 2023 |
| Sites | 1 location across United States |
Indiana University
Adults 18 to 75, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Fecal inulin content will be measured using short acid hydrolysis and high-performance liquid chromatography
| Group | Value | 95% CI |
|---|---|---|
| Healthy Volunteers | 45.2 | 34.6 – 58.6 |
Stool samples will be collected for measurement of measurement of short chain fatty acids (mmol/kg) by liquid chromatography-mass spectrometry
| Group | Value | 95% CI |
|---|---|---|
| Healthy Volunteers | 207.4 | 159.7 – 375.5 |
Stool samples will be collected for measurement of measurement of short chain fatty acids (mmol/kg) by liquid chromatography-mass spectrometry
| Group | Value | 95% CI |
|---|---|---|
| Healthy Volunteers | 111.5 | 99.4 – 279.7 |
| Group | Value | 95% CI |
|---|---|---|
| Healthy Volunteers | 37.3 | 26.8 – 63.5 |
| Group | Value | 95% CI |
|---|---|---|
| Healthy Volunteers | 51 | 25.1 – 60.3 |
Stool characteristics will be measured using a 4 day bowel diary (stool frequency, stool form, ease of passage). Bowel frequency indicates the total number of bowel movements in 4 days.
| Group | Value | 95% CI |
|---|---|---|
| Healthy Volunteers | 4 | 4 – 4 |
Baseline dietary intake will be measured using an automated self-administered dietary assessment tool
| Group | Value | 95% CI |
|---|---|---|
| Healthy Volunteers | 2065.9 | 1415.6 – 2666.1 |
Stool characteristics will be measured using a 4 day bowel diary (stool frequency, stool form, ease of passage). Stool form is on a scale from 1 to 7, where 1=hard lumps, 2=lumps sausage, 3=cracked sausage, 4=normal, 5=soft lumps, 6=mushy, 7=watery, summarized on the level of bowel movements. Ease of passage is on a scale from 1 to 7, where 1=manual disimpaction, 2=enema needed, 3=straining needed, 4=normal, 5=urgent without pain, 6=urgent with pain, 7=incontinent, also summarized on the level of bowel movements.
| Group | Value | 95% CI |
|---|---|---|
| Healthy Volunteers | 4 | 3 – 5 |
| Group | Value | 95% CI |
|---|---|---|
| Healthy Volunteers | 4 | 4 – 4 |
The purpose of this study is to evaluate the production of short chain fatty acids (fatty acids are part of your diet) in stool through the measurement of fecal inulin after a one-time ingestion of 10-gram dose of inulin among healthy adult volunteers.
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
Trials testing the same drug.
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05254340.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing